R&D

December 14, 2023 R&D Day 2023 Recap: Following the Science to Deliver on the Promise of RNAi Therapeutics During our 2023 R&D Day, our leadership discussed several exciting innovations and provided a look ahead at the rapid growth and evoltuion of our pipeline. Read More ›
March 10, 2023 Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics Read More ›
June 15, 2020 Rethinking R&D to Prime it for Future Success Much of the world has this romantic notion that drug discovery involves a small numbers of hero scientists toiling away in a lab until – Eureka! Read More ›

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site